Clinical Trial Update: The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action [Phase 2]

View source ↗

Summary

Phase 2 study examining the gut microbiome in Type 1 diabetes and the mechanism of action of metformin, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 1 Diabetes Mellitus

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Heba M. Ismail | Conditions: Type 1 Diabetes, Obesity | Phase 2 | Status: RECRUITING